Focus Areas

Guided by our corporate philosophy, "Happiness, for the Next Generations", Kitazato Corporation is dedicated to developing products that contribute to the advancement of reproductive medicine and fertility treatment.

By providing a comprehensive range of products that cover the entire treatment process, from oocyte retrieval and fertilization to culture, cryopreservation, and embryo transfer, we aim to be the most trusted partner for both patients and healthcare professionals.

Our primary focus areas are as follows:

1. Cryopreservation Technologies for Oocytes and Embryos

Cryopreservation is our representative technology domain, earning high trust in clinical settings worldwide.

• Vitrification and thawing media utilizing ultra-rapid vitrification technology
• The Cryotop® series, designed for the safe preservation of oocytes and embryos
• Continuous improvement of storage devices with a focus on usability and reproducibility
• Ongoing technological innovation to improve post-thaw survival rates

As products used in approximately 110 countries worldwide,
we will continue to refine these foundational technologies essential to the advancement of reproductive medicine.

2. Medical Devices Supporting Reproductive Treatment Processes

We place strong emphasis on the development of catheters and needles that directly influence treatment outcomes, including oocyte retrieval needles, intrauterine insemination (IUI) catheters, and embryo transfer (ET) catheters.

• Development of catheters with high visibility and excellent usability
• Precise manual fine-tuning performed on each individual product
• Customization capabilities at the millimeter to micrometer level
• A comprehensive product lineup supporting IVF and ICSI procedures from start to finish

By actively incorporating feedback from healthcare professionals,
we continue to develop products that are safer, more user-friendly, and better aligned with clinical needs.

3. Advancement of Core Technologies in Culture Media and Solution

Kitazato Corporation also places strong emphasis on the research and development of culture media and solution essential to reproductive medicine.

• Media and solution used for the washing and culture of oocytes and sperm
• High-quality media optimized for cryopreservation
• Research into optimizing fertilization and culture environments
• Continuous improvements reflecting the needs of clinical practice

This is a critical focus area for improving treatment success rates and ensuring safety in reproductive medicine,
through ongoing research into raw materials, formulations, and product stability.

Future Initiatives

• Strengthening collaborative research with clinics and universities in Japan and overseas
• Adoption of advanced technologies such as AI, new materials, and microfluidics
• Development systems aligned with international regulatory requirements (FDA, CE, CFDA, etc.)
• Strengthening product lineups for global market expansion

Kitazato Corporation will continue to work closely with clinical partners, sharing challenges and advancing product development to support the future of reproductive medicine.